MAXIPHARMA A/S: Financial statements 2021
CVR: 87375617
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,682,816 and a net result of DKK 988,341 compared with DKK 746,390 the year before. That is an increase of 9.7% compared with the year before. Equity in the 2021 report amounted to DKK 3,682,953. The solvency ratio was 72.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,682,816
- Profit/Loss
- DKK 988,341
- Equity
- DKK 3,682,953
- Total Assets
- DKK 5,068,599
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 1.7 mio. | 988 t. | 3.7 mio. | 2 |
| 2020 | - | 1.5 mio. | 746 t. | 3.4 mio. | 2 |
| 2019 | - | 1.4 mio. | 774 t. | 2.8 mio. | 2 |
| 2018 | - | 1.6 mio. | -102 t. | 2.1 mio. | 2 |
| 2017 | - | 1.4 mio. | 323 t. | 2.4 mio. | 2 |
Official annual report
Find more companies like MAXIPHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
MAXIPHARMA A/S has published its annual report for 2020. Gross profit came to DKK 1,534,434, and the net result was DKK 746,390.
As of March 4, 2021, Benedikte Mailand Jensen has joined the board of directors of MAXIPHARMA A/S.
As of March 4, 2021, Jens Indahl Henning has left the board of directors of MAXIPHARMA A/S.
About MAXIPHARMA A/S
MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The board consists of Benedikte Mailand Jensen (chair), Henrik Bencke and Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.